Colorado study finds THC labels often miss actual flower potency
THC Labeling Discrepancies Across Cannabis Flower Product Subtypes in a State-Legal Market.
AI Summary
This study asked how accurately recreational cannabis flower products were labeled for THC in Colorado’s state-legal market. Researchers purchased 265 products from 59 licensed dispensaries between November 2022 and March 2025 and compared labeled THC concentrations with laboratory-observed concentrations. Products were considered accurate when the observed value fell within ±15% of the label; the analysis included pre-pack, pre-roll, re-pack, and deli flower products.
Only 51.7% of sampled flower products met the accuracy standard, and labeling accuracy varied by product subtype. Pre-roll products were more likely to be over-labeled, while re-pack products had the highest proportion of over-labeled products (96.0%); pre-rolls also showed the greatest deviation from their labels (19.6%). This is an observational product-testing study, not a human consumption trial, so it cannot determine how discrepancies affect dosing, consumer behavior, health, or trust. Because the abstract reports products purchased in Colorado only, its findings may not represent every legal cannabis market. This is an abstract-based summary and does not claim review of the full text.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More THC research papers you might find interesting.
Review finds mixed evidence on cannabis and tobacco co-use effects
Review finds promise in acidic cannabinoids, but human benefits remain unproven
A cancer-pain case report raises concern about THC/CBD with opioids
Explore More Research
Stay informed about the latest cannabis science.